Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | 0.00% | +10.06% | +572.25% |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | - | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Valerie Jansen
CTO | Chief Tech/Sci/R&D Officer | 46 | - |
David Dornan
CTO | Chief Tech/Sci/R&D Officer | 46 | 22-03-13 |
Candice Masse
IRC | Investor Relations Contact | - | - |
Robert Yang
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Darcy Mootz
BRD | Director/Board Member | - | Jan. 17 |
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,691,171 | 51,808,323 ( 94.73 %) | 52,909 ( 0.0967 %) | 94.73 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+572.25% | 197M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ELEV Stock
- Company Elevation Oncology, Inc.